WCG
TMO icon

Weaver Consulting Group’s Thermo Fisher Scientific TMO Stock Holding History

Weaver Consulting Group’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-76
Closed -$34K – 827
2020
Q3 		$34K Hold
76
– – 0.02% 320
2020
Q2 		$28K Buy
76
+9
+13% +$3.02K 0.02% 334
2020
Q1 		$19K Buy
67
+10
+18% +$3.15K 0.01% 340
2019
Q4 		$17K Buy
57
+17
+43% +$5.16K 0.01% 391
2019
Q3 		$11K Hold
40
– – 0.01% 462
2019
Q2 		$12K Hold
40
– – 0.01% 422
2019
Q1 		$11K Buy
+40
New +$9.96K ﹤0.01% 908

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Weaver Consulting Group's TMO Position: Q4 2020 in Review

Weaver Consulting Group sold out of Thermo Fisher Scientific (TMO) in Q4 2020, closing a stake of 76 shares — an estimated $34K sold.

Weaver Consulting Group first reported a position in TMO in Q1 2019 and held it in 7 quarters. The position peaked at $34K in Q3 2020. 2,030 funds tracked by Wall St. Rank hold TMO as of Q4 2020.

  • Weaver Consulting Group reported no remaining Thermo Fisher Scientific position as of Q4 2020 after selling out during the quarter.
  • Weaver Consulting Group sold 76 Thermo Fisher Scientific shares in Q4 2020, an estimated $34K.
  • Weaver Consulting Group first reported a position in Thermo Fisher Scientific in Q1 2019 and held it in 7 quarters.
  • Weaver Consulting Group's Thermo Fisher Scientific position peaked at $34K in Q3 2020.
  • 2,030 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q4 2020.

Based on Weaver Consulting Group's 13F filing for Q4 2020, filed 29 Jan 2021.